- Home
- RELX vs CI Comparison
RELX vs CI Comparison
Compare RELX & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELX | CI |
|---|---|---|
| Founded | 1903 | 1792 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.3B | 76.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RELX | CI |
|---|---|---|
| Price | $41.43 | $275.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | N/A | ★ $358.29 |
| AVG Volume (30 Days) | ★ 1.9M | 1.6M |
| Earning Date | 02-12-2026 | 01-29-2026 |
| Dividend Yield | 2.11% | ★ 2.18% |
| EPS Growth | 3.29 | ★ 114.09 |
| EPS | 1.42 | ★ 22.63 |
| Revenue | $13,062,063,298.00 | ★ $268,077,000,000.00 |
| Revenue This Year | $6.02 | $12.85 |
| Revenue Next Year | $6.61 | $4.62 |
| P/E Ratio | $28.16 | ★ $12.22 |
| Revenue Growth | 2.48 | ★ 15.26 |
| 52 Week Low | $39.31 | $239.51 |
| 52 Week High | $56.33 | $350.00 |
Technical Indicators
Market Signals| Indicator | RELX | CI |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 52.78 |
| Support Level | $40.96 | $272.56 |
| Resistance Level | $41.18 | $275.94 |
| Average True Range (ATR) | 0.37 | 4.36 |
| MACD | 0.24 | 0.82 |
| Stochastic Oscillator | 95.67 | 87.85 |
Price Performance
Historical ComparisonAbout RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
About CI The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.